327 related articles for article (PubMed ID: 17959861)
41. Reduced large elastic artery stiffness with regular aerobic exercise in middle-aged and older adults: potential role of suppressed nuclear factor κ B signalling.
Jablonski KL; Donato AJ; Fleenor BS; Nowlan MJ; Walker AE; Kaplon RE; Ballak DB; Seals DR
J Hypertens; 2015 Dec; 33(12):2477-82. PubMed ID: 26378681
[TBL] [Abstract][Full Text] [Related]
42. Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseases.
Hasan I; Rainsford KD; Ross JS
Inflammopharmacology; 2023 Dec; 31(6):2781-2797. PubMed ID: 37758933
[TBL] [Abstract][Full Text] [Related]
43. Does Glycated Albumin Increase with Body Weight Reduction in Obese Non-Diabetic Subjects?
Koga M; Ishizaka Y; Yamakado M
Ann Clin Lab Sci; 2019 Sep; 49(4):529-533. PubMed ID: 31471344
[TBL] [Abstract][Full Text] [Related]
44. Antisense Inhibition of Protein Tyrosine Phosphatase 1B With IONIS-PTP-1B
Digenio A; Pham NC; Watts LM; Morgan ES; Jung SW; Baker BF; Geary RS; Bhanot S
Diabetes Care; 2018 Apr; 41(4):807-814. PubMed ID: 29439147
[TBL] [Abstract][Full Text] [Related]
45. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
[TBL] [Abstract][Full Text] [Related]
46. The Metabolic Effects of
Rondanelli M; Riva A; Petrangolini G; Allegrini P; Bernardinelli L; Fazia T; Peroni G; Gasparri C; Nichetti M; Faliva MA; Naso M; Perna S
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33126534
[TBL] [Abstract][Full Text] [Related]
47. Hypolipidemic and insulin sensitizing effects of salsalate beyond suppressing inflammation in a prediabetic rat model.
Hüttl M; Markova I; Miklánková D; Zapletalova I; Kujal P; Šilhavý J; Pravenec M; Malinska H
Front Pharmacol; 2023; 14():1117683. PubMed ID: 37077818
[No Abstract] [Full Text] [Related]
48. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes.
Albarracin CA; Fuqua BC; Evans JL; Goldfine ID
Diabetes Metab Res Rev; 2008; 24(1):41-51. PubMed ID: 17506119
[TBL] [Abstract][Full Text] [Related]
49. An overview of salsalate as a potential antidiabetic therapy.
Desouza CV
Drugs Today (Barc); 2010 Nov; 46(11):847-53. PubMed ID: 21225023
[TBL] [Abstract][Full Text] [Related]
50. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
51. Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects.
Cincotta AH; Meier AH
Diabetes Care; 1996 Jun; 19(6):667-70. PubMed ID: 8725871
[TBL] [Abstract][Full Text] [Related]
52. Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments.
Won HK; Kim KJ; Lee BW; Kang ES; Cha BS; Lee HC
Diabet Med; 2012 Jan; 29(1):74-9. PubMed ID: 21781151
[TBL] [Abstract][Full Text] [Related]
53. Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients.
Derosa G; Maffioli P; Ferrari I; Palumbo I; Randazzo S; D'Angelo A; Cicero AF
J Clin Pharm Ther; 2011 Oct; 36(5):592-601. PubMed ID: 21070297
[TBL] [Abstract][Full Text] [Related]
54. Addition of benfluorex to biguanide improves glycemic control in obese non-insulin-dependent diabetes: a double-blind study versus placebo.
Roger P; Auclair J; Drain P
J Diabetes Complications; 1999; 13(2):62-7. PubMed ID: 10432168
[TBL] [Abstract][Full Text] [Related]
55. A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia.
Saito I; Azuma K; Kakikawa T; Oshima N; Hanson ME; Tershakovec AM
Lipids Health Dis; 2015 May; 14():40. PubMed ID: 25929253
[TBL] [Abstract][Full Text] [Related]
56. No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet.
Due A; Flint A; Eriksen G; Møller B; Raben A; Hansen JB; Astrup A
Diabetes Obes Metab; 2007 Jul; 9(4):566-74. PubMed ID: 17587399
[TBL] [Abstract][Full Text] [Related]
57. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
58. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.
Hollander PA; Elbein SC; Hirsch IB; Kelley D; McGill J; Taylor T; Weiss SR; Crockett SE; Kaplan RA; Comstock J; Lucas CP; Lodewick PA; Canovatchel W; Chung J; Hauptman J
Diabetes Care; 1998 Aug; 21(8):1288-94. PubMed ID: 9702435
[TBL] [Abstract][Full Text] [Related]
59. Intensive insulin therapy combined with metformin in obese type 2 diabetic patients.
Fritsche A; Schmülling RM; Häring HU; Stumvoll M
Acta Diabetol; 2000 Mar; 37(1):13-8. PubMed ID: 10928231
[TBL] [Abstract][Full Text] [Related]
60. Serum glycated albumin, but not glycated haemoglobin, is low in relation to glycemia in hyperuricemic men.
Koga M; Murai J; Saito H; Mukai M; Kasayama S
Acta Diabetol; 2010 Jun; 47(2):173-7. PubMed ID: 19924375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
